---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-24-000345"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:45:06.512873+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences reprices options to $1.55, resets vesting over 3 years for retention

## Summary
- Compensation Committee amends options with exercise price ≥$1.99 to new price of $1.55 (Feb 28 closing).
- New vesting: 1/3 vests on first anniversary, then 1/36 monthly; all previously unvested shares reset.
- CEO Greg Gorgas holds 274,308 option shares with original range $3.15-$39.90 affected.
- Change applies to employees and non-employee directors; no new dilution from additional grants.
- Company aims to retain key contributors while preserving cash resources.

## SEC filing metadata
- accession: 0001640334-24-000345
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033424000345/0001640334-24-000345-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033424000345/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-24-000345
- JSON: https://secwatch.observer/filing/0001640334-24-000345.json
- Plain text: https://secwatch.observer/filing/0001640334-24-000345.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.